Suggestions for radiation oncologists to overcome radiotherapy interruption in patients with nasopharyngeal cancer
- PMID: 31656779
- PMCID: PMC6789314
- DOI: 10.21037/atm.2019.07.18
Suggestions for radiation oncologists to overcome radiotherapy interruption in patients with nasopharyngeal cancer
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.Radiother Oncol. 2019 Mar;132:178-187. doi: 10.1016/j.radonc.2018.10.018. Epub 2018 Nov 14. Radiother Oncol. 2019. PMID: 30448002 Free PMC article.
References
-
- Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16. 10.1016/S0360-3016(00)00663-5 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources